Design of a Redox-Sensitive Supramolecular Protein Assembly System Operating in Live Cells
Source abstract
Abstract
A fusion construct between Citrine (a YFP variant) and human ferritin (H-chain) was recently shown to form supramolecular assemblies of micrometer size when expressed in mammalian cells. The assembly process is driven by weak hydrophobic interactions leading to dimerization of YFP. Protein assembly could be suppressed at the gene level by mutation in the primary sequence of the construct. In this work, we describe the engineering of a self-assembly interface sensitive to redox state in the cell. Key hydrophobic residues of YFP were mutated systematically to cysteines. Supramolecular assembly of the Citrine-ferritin construct was in some cases preserved by formation of disulfide bonds in place of hydrophobic interactions. In others cases, assembly was abolished, resulting in a diffuse distribution of the expressed protein. A specific variant that remained diffuse under normally reducing intracellular conditions was found to self-assemble rapidly upon exposure to a thiol-specific oxidizing reagent.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Protein Structure and Dynamics · Amino Acid Enzymes and Metabolism · Supramolecular Self-Assembly in Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials and Interfaces, Weizmann Institute of Science, Rehovot 76100, Israel
Funding
Israel Science Foundation · Gerhardt M.J. Schmidt Minerva Center on Supramolecular Architecture, Weizmann Institute of Science
References (22)
Show source-provided references
1. Henriksen A. · EMBO J. · 2001 · 20 · 585310.1093/emboj/20.21.5853 ↗
2. 10.1016/j.bbagen.2013.05.03010.1016/j.bbagen.2013.05.030 ↗
3. 10.1002/biot.20130019910.1002/biot.201300199 ↗
4. 10.1016/j.yjmcc.2013.12.02310.1016/j.yjmcc.2013.12.023 ↗
5. 10.1016/j.bbrc.2014.12.09510.1016/j.bbrc.2014.12.095 ↗
6. 10.1177/108705711349963410.1177/1087057113499634 ↗
7. 10.1016/j.freeradbiomed.2013.07.03310.1016/j.freeradbiomed.2013.07.033 ↗
8. 10.1074/jbc.M31284620010.1074/jbc.M312846200 ↗
9. 10.1016/j.bbabio.2014.01.02010.1016/j.bbabio.2014.01.020 ↗
10. 10.1371/journal.pone.009836210.1371/journal.pone.0098362 ↗
11. 10.1038/ncomms962410.1038/ncomms9624 ↗
12. 10.1016/S0009-8981(03)00200-610.1016/S0009-8981(03)00200-6 ↗
13. 10.1016/j.bbagen.2014.11.01010.1016/j.bbagen.2014.11.010 ↗
14. 10.1080/1521654070119694410.1080/15216540701196944 ↗
15. 10.1002/anie.20130916310.1002/anie.201309163 ↗
16. 10.1038/nchembio.116310.1038/nchembio.1163 ↗
17. 10.1002/anie.20110146710.1002/anie.201101467 ↗
18. 10.1038/nbt1096-124610.1038/nbt1096-1246 ↗
19. 10.1074/jbc.M10281520010.1074/jbc.M102815200 ↗
20. 10.1002/jcc.2008410.1002/jcc.20084 ↗
21. 10.1016/j.bbamcr.2007.10.01310.1016/j.bbamcr.2007.10.013 ↗
22. 10.1021/acs.biomac.5b0043510.1021/acs.biomac.5b00435 ↗